UNITED ~~STATES~~STATESSECURITIES ~~SECURITIES~~ AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K

CURRENT ~~REPORT~~REPORTPursuant ~~Pursuant~~ to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~June~~May 3028, ~~2008~~2009 Date of Report (Date of ~~earliest~~ earliest event reported)

BALSAM VENTURES, INC. (Exact name of registrant as specified in its charter)

NEVADA	000-32011	52-2219056
(State or other jurisdiction of	(Commission File	(IRS Employer Identification No.)
incorporation)	Number)
Suite 410-103 East Holly Street, National Bank
Building Bellingham, WA		98225
(Address of principal executive offices)		(Zip Code)

1480 Gulf Road, Suite 204
Point Roberts, WA	98281
(Address of principal executive offices)	(Zip Code)

(360) 306-1133
Registrant's telephone number, including area code

(360) 306-0230 Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

____ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

____ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

____ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

____ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

SECTION ~~1 REGISTRANT’S~~7 ~~BUSINESS~~– ~~AND~~REGULATION ~~OPERATIONS~~ FD

ITEM 17.01 ~~ENTRY~~REGULATION ~~INTO~~FD ~~A MATERIAL DEFINITIVE AGREEMENT~~DISCLOSURE

OnApproval June 30, 2008, Balsam Ventures, Inc. (the “Company”) entered into a Release Agreement with Norpac Technologies, Inc. (“Norpac”), pursuant to which the Company agreed to release Norpac from any legal claims and liabilities in connection with a license agreement dated November 30, 2003, as amended on January 12, 2006, (the “License Agreement”) between the Company and Norpac (the “Release”). Under the terms of the License Agreement, Norpac had previously granted a license to the Company over its self chilling beverage container technology. However, Norpac’s patents over this technology expired. As such, in exchange 1-for-20 ~~the~~Reverse ~~Release,~~Stock ~~Norpac agreed to:~~ Split

(a)	surrender for cancellation the 5,545,000 shares of the Company’s common stock which were issued to Norpac under the License Agreement; and
(b)	assign an indebtedness owed to Norpac of approximately $612,000 plus accrued interest to the Company. Readers are cautioned that there is substantial doubt that the Company will be able to collect any or all of this indebtedness.

On May 28, 2009, the sole director of Balsam Ventures, Inc. (the “Company”) approved a one-for-twenty reverse split of the Company’s common stock (the “Reverse Stock Split”). The Company’s sole director believes that tightening the capital structure by completing the Reverse Stock Split will assist the Company in obtaining the financing required to assist the Company in pursuing a new business opportunity.

~~The~~Upon ~~summary~~completion of the ~~foregoing~~Reverse isStock ~~qualified~~Split, inthe ~~its~~Company’s authorized ~~entirety~~capital byof common stock will be decreased from 100,000,000 shares, ~~reference~~par value $0.001 per share, to ~~the~~5,000,000 ~~Release~~shares, ~~Agreement~~par value $0.001 per share, ~~which~~and the isissued ~~included~~and asoutstanding ancommon ~~exhibit~~stock towill ~~this~~be reduced from 30,681,663 shares ~~Current~~to ~~Report~~approximately on1,534,084 ~~Form~~shares ~~8-K~~(subject to rounding up in the case of fractional shares). The Reverse Stock Split is expected to be effective June 29, 2009.

~~SECTION 2 FINANCIAL INFORMATION~~ SIGNATURE

~~ITEM~~Pursuant ~~2.01~~to ~~COMPLETION~~the OFrequirements ~~ACQUISITION~~of ORthe ~~DISPOSITION~~Securities OFExchange ~~ASSETS~~Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

The details of the Release Agreement are described under Item 1.01 of this Current Report on Form 8-K.

	BALSAM VENTURES, INC.

Date: June 2, 2009
	By:	/s/ John Boschert

		JOHN BOSCHERT
		Chief Executive Officer, Chief Financial Officer
		President, Secretary and Treasurer
		and Director

~~SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS~~ 2

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

Exhibit
Number		Description of Exhibit
10.1		Release Agreement dated June 30, 2008 between Balsam Ventures, Inc. and Norpac Technologies, Inc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BALSAM VENTURES, INC.
Date: July 7, 2008
	By:	/s/ John Boschert
		JOHN BOSCHERT
		Chief Executive Officer, Chief Financial Officer
		President, Secretary and Treasurer
		and Director

Filing Compare · BALSAM VENTURES INC